We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

85 hedge funds and large institutions have $129M invested in ImmunityBio in 2020 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more capital invested

Capital invested by funds: $17.6M → $129M (+$111M)

360% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 10

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

73% more funds holding

Funds holding: 49 → 85 (+36)

3.71% more ownership

Funds ownership: 6.19% → 9.9% (+3.7%)

20% less call options, than puts

Call options by funds: $5.27M | Put options by funds: $6.59M

Holders
85
Holders Change
+36
Holders Change %
+73.47%
% of All Funds
1.74%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
46
Increased
25
Reduced
9
Closed
10
Calls
$5.27M
Puts
$6.59M
Net Calls
-$1.32M
Net Calls Change
-$1.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.77M
2
CH
CVI Holdings
Delaware
+$4.45M
3
Citadel Advisors
Citadel Advisors
Florida
+$2.88M
4
State Street
State Street
Massachusetts
+$2.82M
5
Invesco
Invesco
Georgia
+$2.41M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$9.36M
2
Millennium Management
Millennium Management
New York
-$873K
3
Goldman Sachs
Goldman Sachs
New York
-$232K
4
HKAM
Horizon Kinetics Asset Management
New York
-$170K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$128K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$25.2M +$7.77M +1,376,606 +204%
Vanguard Group
2
Vanguard Group
Pennsylvania
$21.3M +$1.93M +341,483 +25%
CH
3
CVI Holdings
Delaware
$9.68M +$4.45M +787,863 New
Citadel Advisors
4
Citadel Advisors
Florida
$6.27M +$2.88M +510,798 New
State Street
5
State Street
Massachusetts
$6.25M +$2.82M +498,841 +4,751%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$6.03M +$958K +169,729 +53%
Invesco
7
Invesco
Georgia
$5.51M +$2.41M +426,903 +1,932%
Northern Trust
8
Northern Trust
Illinois
$4.72M +$1.74M +308,693 +409%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$4.59M +$73.4K +13,003 +4%
CIBC World Market
10
CIBC World Market
Ontario, Canada
$4.3M +$1.98M +350,000 New
Morgan Stanley
11
Morgan Stanley
New York
$3.47M +$1.22M +216,945 +331%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$2.66M +$13.9K +2,460 +1%
Charles Schwab
13
Charles Schwab
California
$2.53M +$214K +37,948 +23%
MS
14
Maven Securities
Jersey
$2.27M +$1.05M +185,231 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$2.22M +$412K +72,991 +68%
Millennium Management
16
Millennium Management
New York
$2.07M -$873K -154,658 -48%
N
17
Nuveen
North Carolina
$1.39M +$637K +112,796 New
ECM
18
ExodusPoint Capital Management
New York
$1.2M +$89.5K +15,850 +19%
MIC
19
Meridian Investment Counsel
California
$1.18M +$544K +96,433 New
JP Morgan Chase
20
JP Morgan Chase
New York
$1.07M +$318K +56,332 +182%
Jane Street
21
Jane Street
New York
$794K +$365K +64,653 New
AllianceBernstein
22
AllianceBernstein
Tennessee
$785K +$361K +63,900 New
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$782K +$359K +63,650 New
Creative Planning
24
Creative Planning
Kansas
$763K +$74.7K +13,225 +27%
Barclays
25
Barclays
United Kingdom
$670K +$308K +54,516 +136,290%
1
2 3 4

IBRX Hedge Fund Activity: Q2 2020 in Review

85 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q2 2020, worth a combined $129M — up 633% from $17.6M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new IBRX positions and 10 closed out — a net gain of 36 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $7.77M. The largest seller was Renaissance Technologies, cutting an estimated $9.36M.

  • 85 institutional investors held ImmunityBio (IBRX) as of Q2 2020, up from 49 in Q1 2020.
  • Funds reported $129M of ImmunityBio stock for Q2 2020, up 633% quarter-over-quarter.
  • 46 funds opened new ImmunityBio positions in Q2 2020 and 10 closed out, a net change of +36 holders.
  • The largest ImmunityBio buyer in Q2 2020 was BlackRock, an estimated $7.77M added.
  • The largest ImmunityBio seller in Q2 2020 was Renaissance Technologies, an estimated $9.36M sold.

Based on aggregated 13F filings for Q2 2020.